반응식
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[CH2:8][CH2:9][C:10](O)=[O:11].[Cl:13][C:14]1[CH:15]=[CH:16][CH:17]=[C:18]2[C:27]=1[C:21]1([CH2:26][CH2:25][NH:24][CH2:23][CH2:22]1)[CH2:20][CH:19]2[CH2:28][C:29]([O:31]CC)=[O:30]>>[Cl:13][C:14]1[CH:15]=[CH:16][CH:17]=[C:18]2[C:27]=1[C:21]1([CH2:22][CH2:23][N:24]([C:10](=[O:11])[CH2:9][CH2:8][C:3]3[CH:4]=[CH:5][CH:6]=[CH:7][C:2]=3[Cl:1])[CH2:25][CH2:26]1)[CH2:20][CH:19]2[CH2:28][C:29]([OH:31])=[O:30]참가 물질
3
실험 절차
The title compound was prepared following a procedure analogous to that described in Example 1 using 3-(2-chlorophenyl)propanoic acid and ethyl 2-(7-chloro-2,3-dihydrospiro[indene-1,4′-piperidine]-3-yl)acetate followed by a procedure analogous to that in Example 2. LC-MS Method 1 tR=1.87, min, m/z=446
출처 및 근거
- ORD 기록
- ord-303b22150aca4edc9c24f486f8152fec
- 출처 데이터셋
- uspto-grants-2013_02
- 특허 번호
- US08383629B2
연결된 노트
불러오는 중…